Medical device using bioabsorbable material

An electrospun mitral chordae device consisting essentially of:

• a stand-alone bioabsorbable fibrous network, wherein the bioabsorbable fibrous network has a tensile strength of at least about 0.1 MPa, a suture retention of at least about 0.5 N, and pores with a pore size in between 1 to 300 micrometers allowing cell infiltration and cell ingrowth throughout the thickness of the bioabsorbable fibrous network, wherein the bioabsorbable fibrous network has electrospun polymers, or a matrix with one or more supramolecular compounds with a fiber diameter of 1 micrometer to 50 micrometer, wherein the bioabsorbable fibrous network is an electrospun material having a gradient in properties of the electrospun material, and wherein upon implantation the bioabsorbable fibrous network is capable of progressively being absorbed by a body and replaced by new tissue growth to replace the bioabsorbable fibrous network.

An electrospun mitral chordae device comprising:

• a stand-alone bioabsorbable fibrous network, wherein the bioabsorbable fibrous network has a tensile strength of at least about 0.1 MPa, a suture retention of at least about 0.5 N, and pores with a pore size in between 1 to 300 micrometers allowing cell infiltration and cell ingrowth throughout the thickness of the bioabsorbable fibrous network, wherein the bioabsorbable fibrous network has electrospun polymers, or a matrix with one or more supramolecular compounds with a fiber diameter of 1 micrometer to 50 micrometer, wherein the bioabsorbable fibrous network has a coefficient of friction below 0.8, and wherein upon implantation the bioabsorbable fibrous network is capable of progressively being absorbed by a body and replaced by new tissue growth to replace the bioabsorbable fibrous network.

An electrospun mitral chordae device consisting essentially of:

• a stand-alone bioabsorbable fibrous network, wherein the bioabsorbable fibrous network has a tensile strength of at least about 0.1 MPa, a suture retention of at least about 0.5 N, and pores with a pore size in between 1 to 300 micrometers allowing cell infiltration and cell ingrowth throughout the thickness of the bioabsorbable fibrous network, wherein the bioabsorbable fibrous network has electrospun polymers, or a matrix with one or more supramolecular compounds with a fiber diameter of 1 micrometer to 50 micrometer, wherein the bioabsorbable fibrous network has a coefficient of friction below 0.8, and wherein upon implantation the bioabsorbable fibrous network is capable of progressively being absorbed by a body and replaced by new tissue growth to replace the bioabsorbable fibrous network.